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Objective/background: Nontuberculous mycobacteria (NTM) infection associated with pul-
monary and extrapulmonary disease has been increasing globally. Despite an increase in
incidence rate of NTM infection, its prevalence, species diversity, and circulation pattern
in India is largely unknown. This study sought to investigate the overall burden and diver-
sity of NTM among both pulmonary and extrapulmonary clinical isolates from a Northern
Indian population. Methods: The study was conducted in the Department of Microbiology,
from January 2013 to December 2015. A total of 4620 clinical samples were collected from
patients suspected to have pulmonary and extrapulmonary tuberculosis. Preliminary diag-
nosis was performed using Ziehl–Neelsen staining followed by liquid culture in BacT/
ALERT three-dimensional system. A total of 906 positive cultures obtained were differenti-
ated as either NTM or Mycobacterium tuberculosis complex using a biochemical and MPT64
antigen test. Further identification of NTM species was confirmed with a line probe assay.
Results: Out of 906 cultures isolates, 263 (29.0%) were confirmed as NTM and 643 (71.0%)
were identified as Mycobacterium tuberculosis complex. A total of 79.4% of the NTM were
recovered from pulmonary and 18.2% from extrapulmonary specimens. The diversity of
NTM species was high (13 species) and predominated by Mycobacterium abscessus (31.3%)
followed by Mycobacterium fortuitum (22%), Mycobacterium intracellulare (13.6%), Mycobac-
terium chelonae (9.1%), however,M. abscessus andM. fortuitumwere the predominant species
in both types of clinical isolates. Men (60.4%) and older patients aged greater than 55 years
were the predominated risk group for NTM infection. Conclusion: The high prevalence and
species diversity of NTM suggests the need for immediate and accurate characterization of
NTM for proper treatment and management of patients.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).reli Road,
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Nontuberculous mycobacteria (NTM) has been identified in
human pulmonary and extrapulmonary diseases and are of
great concern for clinicians and microbiologists because of
their increasing global incidence [1]. An increasing pattern
of NTM was recently reported from India with a prevalence
rate from 0.7% to 34% [2,3]. Geographical variance has also
been documented in both prevalence and species spectrum
of NTM. Mycobacterium avium, Mycobacterium fortuitum, and
Mycobacterium scrofulaceum are the most frequently occurring
species as major etiological agents in human infections out of
42 disease-causing NTM species among all known NTM spe-
cies [2,4]. In India, fewer studies have been documented for
the species wise prevalence of NTM in pulmonary and extra-
pulmonary specimens. Depending on the species isolated and
its susceptibility profile, the treatment options differ [5]. Addi-
tionally, most of the NTMs are resistant to the drugs and
antibiotics that are being used to treat the patients infected
with Mycobacterium tuberculosis complex (MTBC). Studies
regarding this aspect are scarce in our geographical location.
Therefore, the determination of the species spectrum of NTM
at a particular geographical location is very necessary.
False diagnosis of NTM as tuberculosis (TB) or multidrug
resistant-TB (MDR-TB) poses a significant challenge for devel-
oping an effective patient care strategy. Conventional meth-
ods like biochemical tests for NTM diagnosis are labor
intensive, error prone, as well as requiring safety procedures
to perform them [6]. However, newer techniques like high per-
formance liquid chromatography, chemiluminescent DNA
probe, nucleic acid amplification, and sequencing of 16S ribo-
somal RNA genes are quite sensitive but require highly
sophisticated and expensive instruments which limits their
utility in clinical diagnosis. However, the GenoType Mycobac-
terium common mycobacteria/additional species assay is
rapid and can accurately differentiate different NTM species.
With this background, the objective of our study is to estimate
the prevalence of NTM among pulmonary and extrapul-
monary isolates and differentiate the NTM species among
both types of pulmonary and extrapulmonary isolates at this
geographical part of the country.
Materials and methods
Study site, design, and ethical clearance
The prospective study was performed at the Sanjay Gandhi
Postgraduate Institute of Medical Sciences, Lucknow. TB sus-
pected patients from visiting indoor patient departments, out-
door patient departments, and variouswards between January
2013 and December 2015 were screened for the study. The
study was approved by the Institutional Ethical Committee of
the Institute and a written informed consent was obtained
from all patients prior to their recruitment in the study.
Data collection
Approximately 2–10 mL of respiratory (sputum, broncho-
alveolar lavage fluid, and lung tissue) and nonrespiratoryspecimens (lymph node aspirate, cold abscesses, pleural
fluid, cerebrospinal fluid, synovial fluid, ascetic fluid, urine,
gastric aspirate, pus, bone marrow, wound, and pus swab)
were collected consecutively from 4620 nonrepeated
patients having extrapulmonary and pulmonary TB. Patients
who belong to north Indian ethnicity were enrolled for the
present study. Patients of all age groups were considered
for the study and included both male and female
populations.Microbiological methods
All the clinical specimens received were subjected to smear
microscopy using the Ziehl–Neelsen (ZN) staining method
[7]. Specimens, which contain normal commensal bacterial
flora, were decontaminated with the standard N-acetyl-L-
cysteine-NaOH method [8]. Specimens were centrifuged
and the sediment was inoculated into the vials of the
BacT/ALERT three-dimensional (3D) system (BioMerieux,
Marcy l’Etoile, France) containing modified Middlebrook
7H9 with an antibiotic supplement (amphotericin B: 0.018%
weight/volume [wt/vol]; azlocillin: 0.0034% wt/vol; nalidixic
acid: 0.04% wt/vol; trimethoprim: 0.00105% wt/vol; poly-
myxin B: 10,000 U; and vancomycin: 0.0005% wt/vol). BacT/
ALERT 3D vials were monitored continuously with the
BacT/ALERT 3D system [9]. Samples with positive growth
vials were removed from the machine and then were sub-
jected to smear microscopy for the presence of acid fast
bacilli (AFB). Samples that failed to show any growth after
6 weeks of incubation in the machine were removed and
treated as negative for mycobacteria.
Cultures with positive growth on the BacT/ALERT 3D and
presence of AFB by ZN stain were screened with biochemical
tests which included niacin production, catalase activity at
68 C at pH 7, and were tested with a rapid TB antigen assay
(SD-Bioline Ag MPT64 Rapid TM assay; Standard Diagnostics,
Kyonggi-do, Korea) which identifies antigens specific to
MTBC. Isolates confirmed as MTB then went through a drug
susceptibility test with the polymerase chain reaction based
Genotype MTBDR plus test (Hain Lifescience, Nehren,
Germany). Cultures with positive growth on BacT/ALERT 3D
and the presence of AFB by ZN stain but that were negative
for MTBC using the SD-Bioline assay were further identified
for the species level.NTM species identification
Characterization of species was carried out with the reverse
hybridization-based line probe assay as per the manufac-
turer’s instructions [10]. Genotype CM (Hain Lifescience,
Nehren Germany) was used for primary identification of the
most common mycobacterium species. Unidentified isolates
or additional mycobacterium species from the above assay
was performed using Genotype Mycobacterium AS kit (Hain
Lifescience, Nehren, Germany). Interpretation of the final results
after hybridization was done based on the presence and
absence of different bands and comparedwith reference band
as provided in the kit.
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The clinical and demographic data were analyzed by using
the SPSS version 19.0 (IBM, NY, USA) software package.
Results
A total of 4,620 clinical specimens were analyzed during this
study period. Of these, 109 (25.6%) and 906 (19.6%) were posi-
tive for AFB by ZN staining and culture method, respectively.
Out of 906 culture isolates, 263 (29.0%) were confirmed as
NTM and 643 (71.0%) were identified as MTBC. Among 263
NTM, 209 (79.4%) were from pulmonary sites and 54 (18.2%)
were from extrapulmonary sites. Mixed infection of mycobac-
terium could not be observed in any case.
Themedian age of NTM-positive patients was 48 years; the
predominant age group was >55 years (36.2%) followed by
26–45 years (30.4%), 46–54 years (18.2%), 18–25 years (10.6%),
and 1–17 years (4.1%) age group, respectively. Men were
(60.4%) more predominant than female (39.5%) patients.
Thirty five cases of type two diabetes mellitus and three cases
of human immunodeficiency virus (HIV) infection were also
found to be positive for NTM (Table 1).
The majority of NTM were isolated from pulmonary spec-
imens, including 189 sputum (74.5%), 19 bronchial lavage/
wash (7.2%), and one lung tissue biopsy (0.38%). In extrapul-
monary specimens, NTM were identified from five urine
(1.9%) specimens, 13 lymph node (3.4%), 19 pus (6.0%), seven
biopsy (2.2%), three pleural fluid (1.1%), two bone marrow
(0.8%), one gastric aspirate (0.8%), two cerebrospinal fluid
(0.8%), one breast tissue (0.8%), and one from ascetic fluid
(0.8%; Table 2).
Diversity of NTM species
A wide range of NTM species (13) were observed (Fig. 1). The
rapid growing species include Mycobacterium abscessus
(31.3%) followed by M. fortuitum (22%) and Mycobacterium
chelonae (9.1%). The slow growing species mainly consisted
of Mycobacterium intracellulare (13.6%), M. avium (7.2%),
Mycobacterium interjectum (3.4%), Mycobacterium simiae (3.4%),
Mycobacterium gordonae (2.6%), M. scrofulaceum (19%),
Mycobacterium kansasii (1.9%), Mycobacterium szulgai (1.7%),Table 1 – Demographic characteristic of nontuberculo
Parameters
Age groups (y)
1–17
18–25
26–45
46–54
>55
Sex
Male
Female
HIV infection
Diabetes mellitus
HIV = human immunodeficiency virus.Mycobacterium malmoense (0.7%), and Mycobacterium inter-
medium (0.7%), respectively (Fig. 1).
NTM species distribution in pulmonary and extrapulmonary
isolates
M. interjectum, M. simiae, M. gordonae, M. kansasii, Mycobac-
terium szulgai, M. intermedium, and M. malmoense were only
reported from pulmonary specimens. Whereas M. abscessus,
M. fortuitum, M. intracellulare, M. chelonae, M. avium, and
M. scrofulaceum were frequently isolated from both types
(Table 2).
Discussion
NTM is an emerging public health problem, especially in
developing countries of the world. MTBC and NTM were
found to be responsible for various pulmonary, skin and soft
tissue, and disseminated infections. Our study addresses
the prevalence of NTM and their species diversity in
pulmonary and extrapulmonary specimens obtain from
Northern Indian population.
In the present study, 29% of NTM were isolated from pul-
monary and extrapulmonary samples. However, NTM was
predominantly reported from pulmonary specimens. Species
found in pulmonary specimens were M. abscessus, M. fortui-
tum, M. intracellulare, M. chelonae, M. avium, M. interjectum, M.
simiae, M. gordonae, M. kansasii, M. szulgai, M. intermedium,
and M. malmoense. In extrapulmonary specimens we found
M. abscessus, M. fortuitum, M. intracellulare, M. chelonae, and
M. scrofulaceun, M. abscessus, and M. fortuitum were common
in both clinical specimens. However, variation in incidence
of NTM reported from different regions of India. In Chandi-
garh, NTM incidence was found to be 7.4%, similarly from
Delhi where it is reported to be around 8.3% and M. fortuitum
was predominant in both places [11,12]. From Kolkata, 17.4%
NTM was documented from sputum [13]. The study con-
ducted in a tertiary care center in South India reported 8.6%
NTM in pulmonary specimens and M. avium/M. intracellulare
were the predominated species [14]. These differences may
be as a result of different geographical distribution of NTM
throughout India. M. scrofulaceum has been reported for the
first time from our center in both pulmonary andus mycobacterial cases.
Sample proportion (N/%)
11 (4.1)
28 (10.6)
80 (30.4)
48 (18.2)
96 (36.2)
159 (60.4)
104 (39.5)
3 (1.1)
35 (13.3)
Table 2 – Sample wise distribution of nontuberculous mycobacteria isolates.
Species
(Mycobacterium)
Sputum Bal Lung
tissue
Pus Urine PF Lymph node Bx Gastric aspirate AF Csf Breast
tissue
BM Total
M. abscessus 59 6 – 9 1 1 1 1 1 1 1 1 – 82
M. fortuitum 38 5 – 7 – 2 4 1 – – – – 2 59
M. intracellulare 25 3 – – 3 – 2 2 – – – – 1 36
M. chelonae 14 2 1 2 1 – 2 2 – – – – – 24
M. avium 16 1 – – – – 2 – – – – – – 19
M. interjectum 9 – – – – – – – – – – – – 9
M. simiae 9 – – – – – – – – – – – – 9
M. gordonae 6 1 – – – – – – – – – – – 7
M. scrofulaceum 1 1 – 1 – – 2 – – – – – – 5
M. kansasii 5 – – – – – – – – – – – – 5
M. szulgai 4 – – – – – – – – – – – – 4
M. malmoense 2 – – – – – – – – – – – – 2
M. intermedium 1 – – – – – – – – – 1 – – 2
Total 189 19 1 19 5 3 13 6 1 1 2 1 3 263
AF = ascitic fluid; Bal = bronchial lavage/wash; BM = bone marrow; Bx = biopsy; Csf = Cerebrospinal fluid; PF = pleural fluid.
Fig. 1 – Diversity of nontuberculosis mycobacteria in pulmonary and extrapulmonary clinical isolates. NTM = nontuberculous
mycobacteria.
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reported from South India.
In an international context, a study involving 30 different
countries from six different continents documented a higher
prevalence of Mycobacterium avium complex from North and
South America and Europe. M. intracellulare was predomi-
nantly reported from South Africa and Australia [15]. This is
in contrast to our study in whichM. abscessus andM. fortuitum
were identified as predominant species among patients withpulmonary and extrapulmonary disease. Our study is in
agreement with previous studies carried out in China, South
Arabia, and Taiwan in which M. abscessus was the predomi-
nant NTM species
[16–19]. The second most common species that was reported
in our study was M. fortuitum which was in agreement with
the finding of a study carried out in Shanghai [20].
Our study shows that men were the predominant risk
group (60.4%), which was in agreement with previous studies
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Patients of a higher age group, above 55 years, were a demo-
graphical risk group for NTM infection in our study. In various
studies the role of older age as a demographic risk factor for
NTM infection has also been previously described [22,23]. This
could be because older people are more prone to preexisting
lung disease, which may favor NTM colonization and
infection.
Diabetes and HIV infection are known to suppress the cel-
lular arm of immunity and hence predispose the patient to
NTM infection. Both are considered as important risk factors
for NTM infection. In the current study, the HIV positivity rate
was found to be lower in NTM patients which is in agreement
with previous studies conducted in China, Denmark, and the
USA, with 0.99%, 2.4%, and 3.4% of HIV infected NTM patients,
respectively [24–27]. We isolatedM. abscessus identified in two
HIV positive patients and M. avium was identified in another
one patient. In the study, 13% cases with diabetes were found
in NTM infected patients. This could be because of the higher
number of diabetic cases reported from India.
In our study, the most frequent NTM species found in pul-
monary and extrapulmonary disease was M. abscessus; this
suggests its high prevalence could be the result of its abun-
dance in this region and its feature of drug resistance and
pathogenicity promote its persistence in this region [28].
Fewer NTM data were reported from India. The reason
could be due to limited funds, disorganized laboratory struc-
ture, other disease burden in the hospital, as well as lack of
awareness among physicians and microbiologists especially
in rural settings. NTM infection is often misdiagnosed with
MDR-TB, as clinical, image findings, and microscopy were
similar in both infections. Also, resistance to first-line drugs
and some second-line drugs often occur in NTM which may
lead to the misdiagnosis of NTM as MDR-TB. A delay in an
accurate diagnosis of NTM leads to an increase in mortality
and morbidity. In summary, our study warrants the need of
patient management as well as the development of preven-
tion strategies against NTM.
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